Director, Precision Medicine

Bristol Myers Squibb•Princeton, NJ
•Hybrid

About The Position

The Director, Precision Medicine provides strategic leadership for the development and delivery of diagnostic products supporting Precision Medicine therapeutic assets at Bristol Myers Squibb. The role oversees diagnostic development, validation, and companion diagnostic (CDx) delivery to enable patient selection and commercial success, and collaborates across the organization to align diagnostic strategies with organizational goals. Expertise in immunohistochemistry and pathology assay development is strongly preferred. The Director leads Precision Medicine strategy and execution for in vitro diagnostic programs, chairs cross-functional matrix teams, and integrates diagnostic biomarkers into exploratory, clinical, regulatory, and medical/commercial strategies. The role also guides diagnostic partnerships and coordinates internal teams and external partners to deliver technical development, validation, clinical validation, and regulatory milestones. The Director contributes to commercial and medical planning, serves as a subject matter expert with internal and external stakeholders, and shares knowledge to build organizational capabilities.

Requirements

  • Advanced technical degree, such as an MSc or PhD.
  • 5–7 years of experience in assay and in vitro diagnostic development, including analytical validation, clinical development, manufacturing, regulatory submission in the U.S. and globally, and commercialization of diagnostics.
  • Broad working knowledge of biomarker and in vitro diagnostic platforms.
  • Demonstrated matrix leadership skills and ability to work effectively across multiple disciplines, internally and externally.

Nice To Haves

  • Expertise in immunohistochemistry and pathology assay development.
  • Experience in the diagnostic and pharmaceutical industries, oncology biomarkers, diagnostic business development, and/or laboratory medicine certification such as ASCP.

Responsibilities

  • Lead Precision Medicine initiatives on asset development, brand, and translational medicine teams where companion or other in vitro diagnostic development is strategic.
  • Develop and execute Precision Medicine strategies for in vitro diagnostic programs, including immunohistochemistry, immunoassay, PCR, and next-generation sequencing for tissue- and blood-based diagnostics, incorporating bioinformatics approaches.
  • Chair Precision Medicine matrix sub-teams to maximize asset value by integrating diagnostic biomarkers into exploratory, clinical, regulatory, and medical/commercial strategies.
  • Provide strategic direction for diagnostic business development, including searching for, evaluating, and transacting diagnostic partnerships.
  • Coordinate internal development and brand teams with external diagnostic partners to deliver technical development, validation, clinical validation, and regulatory milestones.
  • Participate in commercial planning and medical strategy related to diagnostic products.
  • Serve as an internal and external subject matter expert for Precision Medicine, representing BMS to health authorities, medical customers, and at scientific meetings.
  • Acquire and disseminate Precision Medicine knowledge to support organizational learning and capability building.

Benefits

  • Comprehensive benefit plans, including wellbeing support, retirement and financial protection benefits, and medical, dental, vision, life, and disability insurance offerings.
  • Flexible Time Off for eligible U.S.-based exempt employees, subject to manager approval.
  • Paid holidays: 11 company holidays annually; some employee groups also receive three optional holidays.
  • Paid vacation for specified employee groups: 160 hours annually for new hires, subject to manager approval.
  • Depending on eligibility, paid sick leave, up to two paid volunteer days per year, summer-hours flexibility, and leaves of absence for medical, personal, parental, caregiver, bereavement, or military needs.
  • Eligible employees may receive an annual Global Shutdown between Christmas Day and New Year's Day.
  • Potential eligibility for discretionary incentive cash and stock opportunities.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service